Jurisprudence récente: la Cour fédérale n’invalide pas le brevet de Pfizer pour le Viagra

Pfizer Canada Inc. v. Novopharm Limited., 2009 FC 638, (June 18, 2009)

http://decisions.fct-cf.gc.ca/en/2009/2009fc638/2009fc638.html

Questions en litige:

ISSUE NO. 1:    Whether the invention of sildenafil for the treatment of ED was obvious at the time of the priority date 

ISSUE NO. 2: Whether the ‘446 Patent meets the utility requirement by demonstrating or soundly predicting the utility of sildenafil by the Canadian filing date 

ISSUE NO. 3:  Whether the disclosure in the ‘446 Patent met the statutory requirement for disclosure set out in s. 27(3) of the Patent Act as of the ‘446 Patent’s publication date

 

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: